Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease

CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease

US Patent 10928391 · Granted Feb 23, 2021

Estimated economic value: $2,041,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for treating cancer2025
Peptide immunogens targeting interleukin 6 (IL-6) and formulations thereof for i2025
Antibodies and variants thereof against PD-L12024
Converting unorganized medical data for viewing2024
Contextual patient data representation and display2024
Stimulation of mesenchymal stem cell therapeutic activities by T regulatory cell2024
CD6 antibody for treatment of T-cell mediated diseases or disorders2023
CD6 antibody for treatment of T-cell mediated diseases or disorders2023
Genetic locus associated with phytophthora root and stem rot in soybean2021
Compositions and methods of treating a T cell mediated disorder2021
Converting unorganized medical data for viewing2020
CD6 antibody for treatment of T-cell mediated diseases or disorders2020